INFLIXIMAB

INFLIXIMAB was reported 219746 times

INFLIXIMAB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HUMAN ANTICHIMERIC ANTIBODY POSITIVE 309 0.9196
1 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 5784 0.8065
2 RED BLOOD CELL SEDIMENTATION RATE 219 0.7849
3 RHEUMATOID FACTOR POSITIVE 4149 0.7176
4 SWOLLEN JOINT COUNT INCREASED 2272 0.7118
5 PEMPHIGUS 8898 0.7110
6 RHEUMATIC FEVER 3100 0.6948
7 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 444 0.6647
8 GRANULOMA SKIN 530 0.6456
9 DUODENAL ULCER PERFORATION 4779 0.6420
10 DEEP VEIN THROMBOSIS POSTOPERATIVE 1271 0.6345
11 LUPUS VULGARIS 752 0.5968
12 GRIP STRENGTH 136 0.5939
13 C-REACTIVE PROTEIN 542 0.5847
14 HAND DEFORMITY 7596 0.5786
15 FACET JOINT SYNDROME 1848 0.5670
16 SWOLLEN JOINT COUNT 141 0.5640
17 MUSCULOSKELETAL DEFORMITY 129 0.5513
18 VAGINAL FLATULENCE 160 0.5281
19 DRUG SPECIFIC ANTIBODY 699 0.5102
20 C-REACTIVE PROTEIN ABNORMAL 3269 0.5091
21 SYNOVITIS 9112 0.5048
22 HEPATOSPLENIC T-CELL LYMPHOMA 184 0.4960
23 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 1006 0.4851
24 HELICOBACTER INFECTION 4953 0.4814
25 DISLOCATION OF VERTEBRA 1074 0.4704
26 BODY HEIGHT BELOW NORMAL 302 0.4697
27 X-RAY ABNORMAL 833 0.4654
28 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 2726 0.4193
29 MUSCLE INJURY 3463 0.4175
30 ILEOCAECAL RESECTION 143 0.4157
31 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 955 0.4141
32 BLOOD PARATHYROID HORMONE DECREASED 612 0.4127
33 FOLLICULITIS 4219 0.4019
34 RETINITIS 694 0.4014
35 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 224 0.3993
36 HYPOCHOLESTEROLAEMIA 137 0.3881
37 MYCOBACTERIUM MARINUM INFECTION 126 0.3877
38 PERICARDITIS 6382 0.3795
39 GLOSSODYNIA 8489 0.3788
40 LUPUS-LIKE SYNDROME 3400 0.3745
41 BONE EROSION 1255 0.3545
42 PERIPHERAL VENOUS DISEASE 1439 0.3520
43 COLECTOMY TOTAL 193 0.3459
44 PERITONEAL TUBERCULOSIS 150 0.3417
45 DRUG TOLERANCE DECREASED 959 0.3412
46 BLOOD IRON ABNORMAL 330 0.3378
47 CONTRAINDICATED PRODUCT ADMINISTERED 10206 0.3367
48 SYSTEMIC LUPUS ERYTHEMATOSUS 10861 0.3057
49 SERONEGATIVE ARTHRITIS 340 0.2967
50 INTESTINAL RESECTION 1589 0.2952
51 PARADOXICAL PSORIASIS 138 0.2942
52 INFUSION RELATED REACTION 19272 0.2905
53 STEROID DEPENDENCE 255 0.2904
54 FAECAL CALPROTECTIN INCREASED 887 0.2798
55 PANNICULITIS 664 0.2742
56 ENTHESOPATHY 428 0.2735
57 DRUG LEVEL BELOW THERAPEUTIC 1504 0.2724
58 DRUG SPECIFIC ANTIBODY PRESENT 1768 0.2716
59 DISSEMINATED TUBERCULOSIS 697 0.2714
60 TUBERCULOUS PLEURISY 126 0.2664
61 WOUND 7337 0.2622
62 MENINGITIS LISTERIA 130 0.2549
63 RHEUMATOID NODULE 684 0.2481
64 JOINT DESTRUCTION 382 0.2455
65 LYMPH NODE TUBERCULOSIS 179 0.2406
66 RED BLOOD CELL SEDIMENTATION RATE INCREASED 2606 0.2353
67 ANTIBODY TEST POSITIVE 388 0.2336
68 TRANSPLANT DYSFUNCTION 407 0.2279
69 VASCULAR ACCESS COMPLICATION 184 0.2272
70 HODGKIN'S DISEASE 163 0.2248
71 BREAST CANCER STAGE III 1421 0.2192
72 INTESTINAL ANASTOMOSIS 141 0.2189
73 ONYCHOMADESIS 917 0.2183
74 HISTOPLASMOSIS 386 0.2178
75 ILEAL STENOSIS 387 0.2175
76 PYODERMA GANGRENOSUM 779 0.2163
77 HISTOPLASMOSIS DISSEMINATED 342 0.2154
78 PORPHYRIA ACUTE 309 0.2153
79 COLECTOMY 1201 0.2124
80 JUVENILE IDIOPATHIC ARTHRITIS 511 0.2087
81 ANAL FISSURE 1093 0.2036
82 GRIP STRENGTH DECREASED 1753 0.1990
83 INTESTINAL STENOSIS 829 0.1964
84 LIP DRY 1779 0.1957
85 PULMONARY TUBERCULOSIS 826 0.1932
86 IRRITABLE BOWEL SYNDROME 4136 0.1927
87 HYPERCHOLESTEROLAEMIA 1822 0.1885
88 BURSITIS 2286 0.1882
89 SMALL INTESTINAL RESECTION 219 0.1878
90 CATARRH 169 0.1869
91 FISTULA 2096 0.1863
92 CROHN'S DISEASE 1267 0.1847
93 ONYCHOMYCOSIS 810 0.1844
94 FEMALE GENITAL TRACT FISTULA 315 0.1843
95 JOINT RANGE OF MOTION DECREASED 2458 0.1831
96 ANAL FISTULA 976 0.1827
97 TENOSYNOVITIS 491 0.1778
98 ARTHROPATHY 9826 0.1766
99 ILEOSTOMY 451 0.1765
100 WOUND INFECTION 1874 0.1710
101 ARTHRODESIS 173 0.1699
102 LISTERIOSIS 187 0.1691
103 POUCHITIS 145 0.1684
104 PNEUMONIA LEGIONELLA 268 0.1673
105 DRUG LEVEL DECREASED 1687 0.1656
106 ANAL ABSCESS 893 0.1655
107 PUSTULAR PSORIASIS 568 0.1652
108 SINUSITIS BACTERIAL 174 0.1651
109 THERAPEUTIC PRODUCT EFFECT DECREASED 7379 0.1646
110 RHEUMATOID ARTHRITIS 18635 0.1640
111 POLYARTHRITIS 843 0.1597
112 MEAN PLATELET VOLUME DECREASED 134 0.1597
113 INTESTINAL OPERATION 246 0.1553
114 FISTULA DISCHARGE 196 0.1552
115 FIBROMYALGIA 3756 0.1543
116 LIVE BIRTH 1289 0.1539
117 BLEPHAROSPASM 965 0.1531
118 PNEUMOCYSTIS JIROVECI PNEUMONIA 340 0.1525
119 INTENTIONAL PRODUCT USE ISSUE 13123 0.1497
120 ERYTHEMA NODOSUM 509 0.1448
121 DRUG LEVEL ABOVE THERAPEUTIC 662 0.1444
122 NON-HODGKIN'S LYMPHOMA 188 0.1436
123 INFUSION SITE REACTION 429 0.1435
124 RHEUMATOID LUNG 136 0.1424
125 AUTOIMMUNE DISORDER 1387 0.1422
126 COLITIS ULCERATIVE 6235 0.1394
127 PSORIATIC ARTHROPATHY 5612 0.1381
128 IMPAIRED HEALING 4537 0.1380
129 LARGE INTESTINAL STENOSIS 276 0.1379
130 RECTAL ABSCESS 225 0.1340
131 PROCTITIS 374 0.1334
132 ANTINUCLEAR ANTIBODY POSITIVE 428 0.1316
133 TEMPERATURE REGULATION DISORDER 292 0.1309
134 EXPOSURE TO SARS-COV-2 221 0.1299
135 DRUG INTOLERANCE 12550 0.1298
136 NAIL DISORDER 1136 0.1297
137 SERUM SICKNESS 355 0.1272
138 LIVER INJURY 3103 0.1263
139 BASAL CELL CARCINOMA 1970 0.1261
140 SMALL INTESTINAL STENOSIS 132 0.1239
141 JOINT ARTHROPLASTY 222 0.1239
142 FINGER DEFORMITY 597 0.1231
143 C-REACTIVE PROTEIN INCREASED 4483 0.1231
144 DEATH NEONATAL 171 0.1228
145 BODY TEMPERATURE FLUCTUATION 253 0.1213
146 OBESITY 1909 0.1197
147 SCIATICA 1895 0.1187
148 HEPATIC ENZYME INCREASED 8086 0.1185
149 HIP ARTHROPLASTY 1816 0.1185
150 TREATMENT FAILURE 9684 0.1168
151 CHOLANGITIS SCLEROSING 240 0.1167
152 IGA NEPHROPATHY 193 0.1163
153 BLOOD PRESSURE FLUCTUATION 2714 0.1130
154 FREQUENT BOWEL MOVEMENTS 3014 0.1115
155 SALMONELLOSIS 186 0.1102
156 INTESTINAL FISTULA 155 0.1100
157 PULMONARY FIBROSIS 2111 0.1099
158 DEMYELINATION 450 0.1097
159 TYPE 2 DIABETES MELLITUS 3689 0.1095
160 BURNS SECOND DEGREE 191 0.1088
161 ALANINE AMINOTRANSFERASE ABNORMAL 228 0.1080
162 SKIN NECROSIS 559 0.1076
163 UVEITIS 1458 0.1074
164 MUCOUS STOOLS 531 0.1071
165 CONTRAST MEDIA ALLERGY 196 0.1069
166 MATERNAL EXPOSURE TIMING UNSPECIFIED 395 0.1051
167 APPARENT DEATH 378 0.1049
168 POOR VENOUS ACCESS 1080 0.1043
169 INCORRECT DRUG ADMINISTRATION RATE 441 0.1035
170 CYTOMEGALOVIRUS COLITIS 237 0.1030
171 SCLERITIS 164 0.1023
172 COELIAC DISEASE 1004 0.1023
173 APHTHOUS ULCER 786 0.1012
174 KNEE ARTHROPLASTY 2132 0.1012
175 DISCOMFORT 6178 0.1012
176 LOSS OF THERAPEUTIC RESPONSE 322 0.1009
177 LOWER RESPIRATORY TRACT INFECTION 4488 0.0986
178 JOINT SWELLING 11710 0.0969
179 LYMPHOPROLIFERATIVE DISORDER 283 0.0963
180 SWELLING 8981 0.0959
181 ABSCESS 1520 0.0952
182 DERMATITIS PSORIASIFORM 190 0.0929
183 MEAN CELL VOLUME DECREASED 143 0.0927
184 NEOPLASM SKIN 144 0.0927
185 SACROILIITIS 175 0.0926
186 PRESCRIBED OVERDOSE 1779 0.0918
187 EXOSTOSIS 838 0.0917
188 VEIN RUPTURE 153 0.0913
189 TYPE IV HYPERSENSITIVITY REACTION 247 0.0901
190 ANKYLOSING SPONDYLITIS 1188 0.0900
191 ATYPICAL MYCOBACTERIAL INFECTION 127 0.0898
192 HENOCH-SCHONLEIN PURPURA 195 0.0891
193 DRUG TOLERANCE 447 0.0883
194 ABSCESS INTESTINAL 188 0.0872
195 GASTROINTESTINAL STOMA COMPLICATION 137 0.0871
196 INFLAMMATION 4431 0.0858
197 B-CELL LYMPHOMA 291 0.0856
198 INTESTINAL ULCER 135 0.0849
199 FOOT DEFORMITY 938 0.0845
200 INFUSION SITE EXTRAVASATION 526 0.0844
201 BLOOD PRESSURE DIASTOLIC INCREASED 389 0.0842
202 COLOSTOMY 164 0.0834
203 BLOOD CHOLESTEROL INCREASED 3892 0.0834
204 BACK INJURY 906 0.0832
205 WALKING AID USER 547 0.0829
206 PRODUCT LABEL CONFUSION 482 0.0826
207 TREATMENT DELAYED 143 0.0826
208 SERUM FERRITIN DECREASED 142 0.0821
209 BRONCHITIS CHRONIC 200 0.0818
210 LATENT TUBERCULOSIS 171 0.0816
211 CERVICAL DYSPLASIA 175 0.0801
212 BLISTER 4474 0.0796
213 MATERNAL EXPOSURE DURING PREGNANCY 7092 0.0795
214 CLOSTRIDIUM DIFFICILE INFECTION 1735 0.0794
215 TUBERCULIN TEST POSITIVE 200 0.0789
216 MEAN CELL HAEMOGLOBIN DECREASED 144 0.0786
217 HAEMATOCHEZIA 4319 0.0782
218 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 3685 0.0766
219 OSTEOARTHRITIS 3220 0.0759
220 STOMATITIS 4574 0.0753
221 PNEUMONIA VIRAL 240 0.0752
222 ANORECTAL DISORDER 150 0.0752
223 JOINT DISLOCATION 792 0.0748
224 MYCOBACTERIAL INFECTION 129 0.0748
225 LOWER LIMB FRACTURE 1438 0.0748
226 INFECTIOUS MONONUCLEOSIS 166 0.0740
227 LYMPHOMA 1141 0.0738
228 BLOOD PRESSURE DIASTOLIC DECREASED 542 0.0734
229 MUSCULOSKELETAL STIFFNESS 6428 0.0733
230 GAIT INABILITY 2423 0.0724
231 PRODUCT USE ISSUE 13576 0.0722
232 OPPORTUNISTIC INFECTION 132 0.0713
233 SPONDYLITIS 257 0.0706
234 SKIN CANCER 1505 0.0698
235 EXPOSURE DURING PREGNANCY 4327 0.0695
236 DEFAECATION URGENCY 486 0.0693
237 GASTROINTESTINAL INFLAMMATION 543 0.0693
238 WHEELCHAIR USER 308 0.0692
239 SUSPECTED OFF LABEL USE 312 0.0690
240 DIARRHOEA HAEMORRHAGIC 644 0.0688
241 VARICELLA 164 0.0686
242 RADICULOPATHY 180 0.0682
243 CHRONIC SINUSITIS 256 0.0681
244 JOINT EFFUSION 470 0.0681
245 ABDOMINAL ABSCESS 301 0.0680
246 LIVER FUNCTION TEST INCREASED 1451 0.0675
247 GRANULOMA 231 0.0667
248 FOETAL DEATH 343 0.0661
249 MOBILITY DECREASED 4735 0.0658
250 CONDITION AGGRAVATED 20035 0.0658
251 SARCOIDOSIS 310 0.0652
252 CONGENITAL ANOMALY 503 0.0649
253 BODY TEMPERATURE DECREASED 637 0.0646
254 ABDOMINAL DISCOMFORT 10828 0.0645
255 IRITIS 194 0.0638
256 NIGHT SWEATS 2053 0.0637
257 SQUAMOUS CELL CARCINOMA 599 0.0636
258 BRONCHIECTASIS 425 0.0630
259 ULCER HAEMORRHAGE 424 0.0626
260 OVARIAN CYST 626 0.0626
261 IMMUNODEFICIENCY 933 0.0625
262 EYE INJURY 189 0.0622
263 LARGE INTESTINAL ULCER 168 0.0618
264 SUBCUTANEOUS ABSCESS 296 0.0617
265 BREAST CANCER STAGE II 513 0.0616
266 OBSTRUCTION 246 0.0615
267 PRESCRIBED UNDERDOSE 1221 0.0611
268 WEIGHT FLUCTUATION 637 0.0608
269 ALOPECIA 11937 0.0607
270 MALIGNANT MELANOMA 814 0.0607
271 FOOD ALLERGY 464 0.0601
272 CUSHINGOID 192 0.0598
273 HEPATIC CIRRHOSIS 1119 0.0595
274 ILL-DEFINED DISORDER 3599 0.0592
275 TONSILLITIS 307 0.0588
276 THERAPY NON-RESPONDER 2642 0.0587
277 ADENOCARCINOMA 131 0.0584
278 HYPOPNOEA 200 0.0576
279 HEART RATE DECREASED 2013 0.0573
280 ARTHRITIS BACTERIAL 235 0.0572
281 GENERAL PHYSICAL HEALTH DETERIORATION 6586 0.0569
282 RASH VESICULAR 274 0.0566
283 INFLAMMATORY BOWEL DISEASE 553 0.0565
284 DRUG ERUPTION 998 0.0563
285 STREPTOCOCCAL INFECTION 313 0.0562
286 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 4000 0.0562
287 HYPERSENSITIVITY 10432 0.0561
288 TRANSPLANT REJECTION 449 0.0560
289 MYCOBACTERIUM AVIUM COMPLEX INFECTION 150 0.0558
290 SUSPECTED COVID-19 183 0.0554
291 HYPERCALCAEMIA 679 0.0549
292 PREMATURE LABOUR 309 0.0546
293 FINE MOTOR SKILL DYSFUNCTION 158 0.0545
294 ULCER 859 0.0539
295 ARTHRITIS 4241 0.0539
296 INFECTION 7775 0.0537
297 RECTAL CANCER 165 0.0537
298 HERPES ZOSTER 3050 0.0530
299 PROCTALGIA 340 0.0528
300 JOINT STIFFNESS 1385 0.0527
301 NORMAL NEWBORN 285 0.0524
302 LIVER DISORDER 2321 0.0523
303 ADRENAL INSUFFICIENCY 634 0.0522
304 DISABILITY 1033 0.0522
305 GASTROINTESTINAL DISORDER 4678 0.0522
306 MUSCULOSKELETAL PAIN 2726 0.0520
307 LUNG NEOPLASM 221 0.0517
308 LUNG DISORDER 2508 0.0511
309 THERAPEUTIC RESPONSE SHORTENED 1695 0.0511
310 SINUSITIS 5186 0.0506
311 CHONDROPATHY 137 0.0505
312 BLOOD PRESSURE SYSTOLIC INCREASED 985 0.0505
313 SHOULDER ARTHROPLASTY 135 0.0501
314 JOINT LOCK 141 0.0496
315 HIDRADENITIS 452 0.0495
316 CYTOMEGALOVIRUS INFECTION 812 0.0488
317 RECTAL HAEMORRHAGE 2070 0.0481
318 WHEEZING 2811 0.0474
319 ROAD TRAFFIC ACCIDENT 1955 0.0467
320 GROWTH RETARDATION 137 0.0465
321 SENSITIVITY TO WEATHER CHANGE 244 0.0463
322 POSTOPERATIVE WOUND INFECTION 313 0.0463
323 SPINAL FUSION SURGERY 187 0.0460
324 INFLAMMATORY MARKER INCREASED 228 0.0459
325 ALCOHOL POISONING 123 0.0459
326 INJURY 3227 0.0459
327 COLITIS 1739 0.0458
328 SKIN ULCER 1178 0.0455
329 RHINITIS 367 0.0455
330 EAR INFECTION 1209 0.0454
331 OFF LABEL USE 39684 0.0453
332 SMALL INTESTINAL OBSTRUCTION 554 0.0450
333 ADVERSE REACTION 594 0.0448
334 APPENDICECTOMY 159 0.0445
335 TASTE DISORDER 901 0.0444
336 OXYGEN SATURATION ABNORMAL 125 0.0440
337 PERIPHERAL SWELLING 6779 0.0440
338 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 7913 0.0439
339 POST PROCEDURAL INFECTION 357 0.0439
340 ENDOMETRIOSIS 209 0.0438
341 NECK MASS 124 0.0438
342 MONOCYTE COUNT INCREASED 159 0.0437
343 LUNG ADENOCARCINOMA 131 0.0435
344 EPSTEIN-BARR VIRUS INFECTION 272 0.0435
345 ARTHRALGIA 17973 0.0432
346 ENTERITIS 275 0.0429
347 ABSCESS LIMB 183 0.0429
348 LUNG CANCER METASTATIC 123 0.0426
349 FOOT OPERATION 211 0.0426
350 HYSTERECTOMY 369 0.0426
351 ABDOMINAL ADHESIONS 134 0.0424
352 THERAPEUTIC RESPONSE DECREASED 2565 0.0423
353 WEIGHT INCREASED 9467 0.0422
354 DRUG-INDUCED LIVER INJURY 1321 0.0421
355 PHYSICAL DISABILITY 186 0.0420
356 OEDEMA 2269 0.0418
357 GASTROINTESTINAL INFECTION 375 0.0418
358 HEART RATE IRREGULAR 941 0.0416
359 TONGUE DISORDER 300 0.0414
360 AUTOIMMUNE HEPATITIS 287 0.0412
361 PREGNANCY 825 0.0412
362 MYOSITIS 369 0.0411
363 CLOSTRIDIAL INFECTION 138 0.0408
364 SKIN PAPILLOMA 162 0.0404
365 IMMUNOSUPPRESSION 353 0.0400
366 DIVERTICULITIS 1102 0.0397
367 DEFORMITY 369 0.0394
368 PHARYNGITIS STREPTOCOCCAL 426 0.0393
369 SLEEP DISORDER 2777 0.0393
370 MOUTH ULCERATION 829 0.0393
371 HEPATITIS 992 0.0387
372 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 662 0.0386
373 SKIN INFECTION 431 0.0384
374 NODULE 501 0.0383
375 PNEUMOCYSTIS JIROVECII PNEUMONIA 383 0.0381
376 OESOPHAGEAL CANDIDIASIS 152 0.0381
377 PSORIASIS 4973 0.0380
378 NASOPHARYNGITIS 6988 0.0379
379 IRON DEFICIENCY ANAEMIA 349 0.0378
380 CUTANEOUS VASCULITIS 138 0.0378
381 NEPHROLITHIASIS 1721 0.0375
382 HYPERTENSION 7924 0.0374
383 INTESTINAL OBSTRUCTION 1408 0.0373
384 IRON DEFICIENCY 165 0.0367
385 BLOOD IRON DECREASED 433 0.0365
386 PARADOXICAL DRUG REACTION 133 0.0361
387 ANAPHYLACTIC REACTION 1995 0.0361
388 ORAL CANDIDIASIS 473 0.0359
389 URTICARIA 5991 0.0357
390 ADVERSE EVENT 3290 0.0357
391 SYNOVIAL CYST 164 0.0355
392 INTESTINAL PERFORATION 396 0.0352
393 IMPAIRED QUALITY OF LIFE 507 0.0352
394 JOINT INJURY 750 0.0351
395 VAGINAL INFECTION 165 0.0350
396 TOOTH ABSCESS 357 0.0350
397 CONTUSION 3374 0.0350
398 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 263 0.0350
399 EPILEPSY 1070 0.0350
400 UPPER RESPIRATORY TRACT INFECTION 1609 0.0348
401 ABDOMINAL PAIN 8086 0.0347
402 ANAPHYLACTOID REACTION 142 0.0345
403 FAECES SOFT 248 0.0341
404 GENERAL SYMPTOM 255 0.0340
405 HERPES SIMPLEX 221 0.0340
406 ABNORMAL LOSS OF WEIGHT 230 0.0337
407 PHARYNGITIS 416 0.0335
408 VASCULITIS 385 0.0330
409 CERVIX CARCINOMA 129 0.0330
410 DIFFUSE LARGE B-CELL LYMPHOMA 254 0.0329
411 PULMONARY MASS 488 0.0327
412 INTENTIONAL DOSE OMISSION 931 0.0326
413 MELANOCYTIC NAEVUS 143 0.0326
414 EAR PAIN 633 0.0325
415 DELIRIUM 1130 0.0325
416 CANDIDIASIS 130 0.0324
417 DRUG USE DISORDER 272 0.0323
418 CAESAREAN SECTION 376 0.0323
419 HERPES VIRUS INFECTION 184 0.0319
420 PLEURISY 189 0.0318
421 DECREASED IMMUNE RESPONSIVENESS 312 0.0318
422 TOOTH INFECTION 418 0.0317
423 MIGRAINE 3007 0.0315
424 PULMONARY THROMBOSIS 343 0.0314
425 BODY TEMPERATURE INCREASED 641 0.0314
426 ADVERSE DRUG REACTION 2811 0.0313
427 SQUAMOUS CELL CARCINOMA OF SKIN 188 0.0311
428 BRONCHOPULMONARY ASPERGILLOSIS 241 0.0311
429 RASH 13516 0.0310
430 NECK PAIN 1731 0.0309
431 CYST 384 0.0309
432 THROAT TIGHTNESS 834 0.0308
433 COLITIS MICROSCOPIC 145 0.0306
434 PAIN 18754 0.0305
435 BREATH SOUNDS ABNORMAL 150 0.0304
436 DRUG INEFFECTIVE 39960 0.0303
437 COLON CANCER 450 0.0302
438 GINGIVAL PAIN 240 0.0301
439 RED CELL DISTRIBUTION WIDTH INCREASED 125 0.0301
440 STAPHYLOCOCCAL INFECTION 988 0.0299
441 FURUNCLE 237 0.0299
442 HYPOAESTHESIA 4471 0.0298
443 OSTEOPOROSIS 1227 0.0298
444 GASTROENTERITIS 434 0.0297
445 FEAR OF INJECTION 211 0.0295
446 DRUG EFFECT DECREASED 1574 0.0292
447 TENDERNESS 303 0.0290
448 LIMB OPERATION 139 0.0289
449 DRY MOUTH 2343 0.0288
450 MALNUTRITION 323 0.0288
451 MENINGITIS 192 0.0287
452 LIVER FUNCTION TEST ABNORMAL 832 0.0286
453 IMPAIRED WORK ABILITY 609 0.0285
454 TERMINAL STATE 190 0.0284
455 MASS 394 0.0282
456 PALLOR 766 0.0281
457 CARPAL TUNNEL SYNDROME 394 0.0281
458 HEPATIC ENZYME ABNORMAL 140 0.0280
459 GASTROENTERITIS VIRAL 506 0.0280
460 LARGE INTESTINE PERFORATION 194 0.0279
461 CONFUSIONAL STATE 4510 0.0279
462 POLYP 182 0.0278
463 PYREXIA 9605 0.0277
464 RESPIRATORY DISORDER 826 0.0276
465 BOWEL MOVEMENT IRREGULARITY 210 0.0274
466 TENDONITIS 423 0.0273
467 SKIN LESION 745 0.0271
468 WEIGHT DECREASED 7546 0.0270
469 ERYSIPELAS 135 0.0268
470 PANCREATITIS 1408 0.0266
471 HERNIA 513 0.0265
472 APPENDICITIS 247 0.0264
473 SKIN PLAQUE 223 0.0264
474 ORGANISING PNEUMONIA 131 0.0264
475 DYSPEPSIA 2582 0.0262
476 NEOPLASM 301 0.0262
477 MUSCULOSKELETAL DISORDER 498 0.0261
478 MULTIPLE ALLERGIES 205 0.0261
479 BLOOD PRESSURE INCREASED 3976 0.0260
480 SECRETION DISCHARGE 325 0.0259
481 HEPATIC STEATOSIS 483 0.0259
482 LOCALISED INFECTION 626 0.0259
483 CHEST DISCOMFORT 2642 0.0258
484 PNEUMONIA 8352 0.0258
485 CARDIAC MURMUR 222 0.0256
486 VEIN DISORDER 128 0.0256
487 PYELONEPHRITIS 220 0.0254
488 RENAL CELL CARCINOMA 124 0.0253
489 CELLULITIS 1271 0.0252
490 SPINAL PAIN 295 0.0252
491 SURGERY 1476 0.0252
492 ENCEPHALITIS 174 0.0251
493 FLUSHING 2556 0.0251
494 STAPHYLOCOCCAL SEPSIS 124 0.0251
495 CLOSTRIDIUM DIFFICILE COLITIS 266 0.0251
496 ANORECTAL DISCOMFORT 132 0.0248
497 PAROSMIA 187 0.0248
498 HIP SURGERY 134 0.0247
499 BACTERAEMIA 293 0.0247
500 SEPTIC SHOCK 1073 0.0246
501 SKIN LACERATION 268 0.0246
502 COVID-19 4323 0.0246
503 PARAESTHESIA ORAL 355 0.0246
504 SKIN MASS 164 0.0245
505 OSTEOMYELITIS 443 0.0244
506 RASH PUSTULAR 178 0.0244
507 OPTIC NEURITIS 222 0.0244
508 ABNORMAL FAECES 200 0.0244
509 FOOD POISONING 130 0.0242
510 FEELING HOT 1484 0.0242
511 IMMUNE SYSTEM DISORDER 319 0.0242
512 PLATELET COUNT INCREASED 315 0.0241
513 SKIN REACTION 339 0.0240
514 EYE INFECTION 271 0.0240
515 CHEST PAIN 4423 0.0239
516 RASH PRURITIC 1280 0.0236
517 CYANOSIS 370 0.0235
518 ANAL INCONTINENCE 211 0.0234
519 RESPIRATORY RATE INCREASED 208 0.0234
520 SKIN WARM 136 0.0234
521 ARTHROPOD BITE 173 0.0233
522 ESCHERICHIA INFECTION 192 0.0233
523 PNEUMONIA BACTERIAL 214 0.0233
524 MALAISE 10209 0.0233
525 UNDERDOSE 1698 0.0232
526 BLOOD ALBUMIN DECREASED 184 0.0232
527 INFLUENZA 2571 0.0230
528 GINGIVITIS 124 0.0230
529 HAEMORRHOIDS 448 0.0229
530 BREAST MASS 153 0.0228
531 FUNGAL INFECTION 759 0.0227
532 CONCUSSION 176 0.0227
533 VAGINAL DISCHARGE 229 0.0226
534 ASTHMA 2549 0.0225
535 INTERSTITIAL LUNG DISEASE 1091 0.0225
536 SARS-COV-2 TEST POSITIVE 295 0.0223
537 NEOPLASM MALIGNANT 1483 0.0222
538 OROPHARYNGEAL PAIN 2053 0.0222
539 CHOLECYSTECTOMY 253 0.0221
540 ORAL HERPES 432 0.0221
541 UROSEPSIS 204 0.0221
542 LARYNGEAL OEDEMA 134 0.0217
543 HAND FRACTURE 154 0.0217
544 FATIGUE 16917 0.0217
545 SPUTUM DISCOLOURED 206 0.0217
546 LARGE INTESTINE POLYP 150 0.0216
547 GASTROOESOPHAGEAL REFLUX DISEASE 1727 0.0214
548 AMNESIA 1389 0.0213
549 PREMATURE BABY 641 0.0213
550 ACCIDENT 254 0.0212
551 BACTERIAL INFECTION 395 0.0212
552 PRODUCT USE IN UNAPPROVED INDICATION 5232 0.0211
553 KIDNEY INFECTION 414 0.0211
554 TOOTH EXTRACTION 262 0.0210
555 INGUINAL HERNIA 128 0.0210
556 ASPERGILLUS INFECTION 138 0.0210
557 BACK DISORDER 341 0.0210
558 TACHYCARDIA 1861 0.0209
559 ABDOMINAL PAIN UPPER 4272 0.0207
560 BRONCHITIS 1526 0.0206
561 PAIN IN EXTREMITY 6056 0.0205
562 GASTROINTESTINAL PAIN 226 0.0205
563 TOOTH FRACTURE 226 0.0205
564 ANAPHYLACTIC SHOCK 526 0.0204
565 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1119 0.0204
566 VIRAL INFECTION 674 0.0202
567 ALANINE AMINOTRANSFERASE INCREASED 1239 0.0202
568 CYSTITIS 640 0.0201
569 ABORTION SPONTANEOUS 805 0.0201
570 LUNG NEOPLASM MALIGNANT 825 0.0201
571 HYPOKINESIA 289 0.0199
572 ONYCHOCLASIS 137 0.0199
573 ERYTHEMA 4088 0.0199
574 INFUSION SITE SWELLING 125 0.0198
575 LYMPHADENOPATHY 696 0.0196
576 PARAESTHESIA 3086 0.0196
577 POST PROCEDURAL COMPLICATION 374 0.0195
578 WHITE BLOOD CELL COUNT INCREASED 747 0.0195
579 MEDICATION ERROR 1081 0.0194
580 BLOOD PRESSURE DECREASED 1291 0.0194
581 SEPSIS 2167 0.0194
582 MACULAR DEGENERATION 232 0.0194
583 VOMITING 9131 0.0194
584 FLANK PAIN 182 0.0194
585 ASPARTATE AMINOTRANSFERASE INCREASED 1028 0.0193
586 MATERNAL EXPOSURE BEFORE PREGNANCY 132 0.0193
587 OXYGEN SATURATION DECREASED 1073 0.0191
588 PHOTOSENSITIVITY REACTION 315 0.0191
589 IMPAIRED GASTRIC EMPTYING 260 0.0191
590 DYSPNOEA 10780 0.0190
591 PSEUDOMONAS INFECTION 163 0.0190
592 MUSCULAR WEAKNESS 2157 0.0190
593 CATARACT 1124 0.0189
594 RESPIRATORY TRACT INFECTION 489 0.0188
595 PRURITUS 7215 0.0188
596 SPINAL OSTEOARTHRITIS 164 0.0186
597 INFUSION SITE PAIN 240 0.0186
598 DERMATITIS ALLERGIC 234 0.0186
599 EYE INFLAMMATION 176 0.0184
600 GLAUCOMA 353 0.0183
601 INTERVERTEBRAL DISC PROTRUSION 399 0.0182
602 OEDEMA PERIPHERAL 2214 0.0181
603 HEADACHE 11367 0.0181
604 MUSCLE SPASMS 3325 0.0181
605 HEART RATE INCREASED 1795 0.0181
606 ABDOMINAL DISTENSION 1885 0.0180
607 NASAL CONGESTION 1060 0.0180
608 DIVERTICULUM 128 0.0180
609 GROIN PAIN 158 0.0180
610 TUBULOINTERSTITIAL NEPHRITIS 337 0.0180
611 CHILLS 2099 0.0179
612 GAIT DISTURBANCE 3426 0.0179
613 ILEUS 221 0.0178
614 LUNG INFILTRATION 157 0.0178
615 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 300 0.0176
616 QUALITY OF LIFE DECREASED 236 0.0176
617 DECREASED APPETITE 4065 0.0175
618 DRUG RESISTANCE 449 0.0175
619 EMPHYSEMA 176 0.0174
620 RASH ERYTHEMATOUS 824 0.0172
621 DRUG EXPOSURE DURING PREGNANCY 586 0.0172
622 DEEP VEIN THROMBOSIS 1112 0.0171
623 BRONCHOSPASM 244 0.0171
624 HEPATOTOXICITY 380 0.0170
625 BREAST CANCER 1584 0.0170
626 UTERINE LEIOMYOMA 124 0.0169
627 VITAMIN D DECREASED 145 0.0169
628 DIARRHOEA 10888 0.0169
629 TOOTH DISORDER 375 0.0168
630 DRUG LEVEL INCREASED 279 0.0168
631 THERAPY PARTIAL RESPONDER 262 0.0168
632 ECZEMA 870 0.0166
633 ANKLE FRACTURE 256 0.0165
634 DERMATITIS 345 0.0164
635 UPPER LIMB FRACTURE 328 0.0164
636 THYROID CANCER 198 0.0164
637 PELVIC FRACTURE 128 0.0164
638 RENAL CYST 130 0.0164
639 SPINAL DISORDER 155 0.0164
640 WRIST FRACTURE 196 0.0163
641 DRUG EFFECT INCOMPLETE 593 0.0163
642 LIGAMENT SPRAIN 161 0.0163
643 BACK PAIN 3779 0.0162
644 DEPRESSION 3638 0.0160
645 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 468 0.0160
646 MEMORY IMPAIRMENT 2184 0.0159
647 BLOOD DISORDER 127 0.0158
648 NAUSEA 12486 0.0158
649 FOETAL EXPOSURE DURING PREGNANCY 1282 0.0158
650 INJECTION SITE REACTION 1082 0.0157
651 SCAR 269 0.0157
652 CONJUNCTIVITIS 291 0.0157
653 KNEE OPERATION 154 0.0156
654 SENSORY LOSS 126 0.0156
655 EATING DISORDER 333 0.0156
656 SINUS CONGESTION 211 0.0156
657 FOOT FRACTURE 296 0.0156
658 FLUID RETENTION 794 0.0156
659 PNEUMONITIS 424 0.0156
660 SKIN DISORDER 519 0.0155
661 GASTROINTESTINAL CARCINOMA 141 0.0155
662 GASTRIC DISORDER 531 0.0155
663 PULMONARY EMBOLISM 1470 0.0155
664 LABORATORY TEST ABNORMAL 454 0.0154
665 LEUKOPENIA 766 0.0153
666 RHINORRHOEA 986 0.0152
667 PLEURAL EFFUSION 926 0.0152
668 MULTI-ORGAN FAILURE 263 0.0152
669 OVARIAN CANCER 140 0.0152
670 CANDIDA INFECTION 256 0.0151
671 ABDOMINAL PAIN LOWER 382 0.0151
672 OROPHARYNGEAL DISCOMFORT 136 0.0150
673 INTERVERTEBRAL DISC DEGENERATION 139 0.0150
674 INCONTINENCE 158 0.0149
675 LUNG INFECTION 232 0.0149
676 ACUTE RESPIRATORY DISTRESS SYNDROME 262 0.0148
677 BRAIN NEOPLASM 136 0.0148
678 DIABETES MELLITUS 1128 0.0148
679 VITAMIN D DEFICIENCY 144 0.0148
680 TOOTHACHE 267 0.0147
681 DEVICE RELATED INFECTION 227 0.0147
682 ACNE 1114 0.0147
683 ASTHENIA 5493 0.0146
684 SWOLLEN TONGUE 456 0.0146
685 FACE OEDEMA 246 0.0146
686 LIMB DISCOMFORT 451 0.0146
687 TRANSAMINASES INCREASED 324 0.0146
688 INFLUENZA LIKE ILLNESS 1198 0.0145
689 URINARY TRACT INFECTION 2482 0.0145
690 HYPERHIDROSIS 1867 0.0145
691 BEDRIDDEN 190 0.0144
692 LEUKAEMIA 136 0.0144
693 MUSCULOSKELETAL CHEST PAIN 223 0.0144
694 FEELING COLD 400 0.0144
695 ABASIA 355 0.0144
696 GALLBLADDER DISORDER 256 0.0143
697 MUSCULOSKELETAL DISCOMFORT 246 0.0143
698 SCAB 163 0.0143
699 THYROID DISORDER 220 0.0143
700 LOSS OF CONSCIOUSNESS 1816 0.0142
701 HAEMATOCRIT DECREASED 281 0.0142
702 PALPITATIONS 1657 0.0141
703 DISSEMINATED INTRAVASCULAR COAGULATION 199 0.0141
704 GENERALISED OEDEMA 174 0.0140
705 COLD SWEAT 246 0.0139
706 LIMB INJURY 379 0.0139
707 PRESYNCOPE 339 0.0139
708 LACERATION 131 0.0139
709 OESOPHAGITIS 152 0.0139
710 MYOCARDITIS 159 0.0139
711 ATELECTASIS 134 0.0139
712 INSOMNIA 3682 0.0138
713 PAIN IN JAW 391 0.0138
714 THROAT IRRITATION 619 0.0138
715 OSTEOPENIA 209 0.0138
716 MOVEMENT DISORDER 441 0.0137
717 RESPIRATORY DISTRESS 378 0.0137
718 COUGH 3810 0.0136
719 PNEUMOTHORAX 213 0.0134
720 PRODUCTIVE COUGH 641 0.0134
721 PROCEDURAL PAIN 371 0.0134
722 CHOLELITHIASIS 437 0.0133
723 BONE DENSITY DECREASED 416 0.0133
724 HEPATOMEGALY 130 0.0132
725 CARDIOVASCULAR DISORDER 335 0.0132
726 THROMBOSIS 1061 0.0132
727 TENDON RUPTURE 162 0.0131
728 EYE DISORDER 430 0.0131
729 GASTRITIS 344 0.0131
730 PARALYSIS 186 0.0130
731 PHARYNGEAL OEDEMA 199 0.0129
732 HOSPITALISATION 1957 0.0127
733 CHOLECYSTITIS 151 0.0127
734 COVID-19 PNEUMONIA 149 0.0126
735 HAEMOGLOBIN DECREASED 1295 0.0126
736 DIZZINESS 6253 0.0125
737 SYNCOPE 1248 0.0125
738 ROTATOR CUFF SYNDROME 160 0.0124
739 RENAL PAIN 132 0.0124
740 VISUAL IMPAIRMENT 1539 0.0124
741 SPLENOMEGALY 145 0.0124
742 ORAL PAIN 277 0.0124
743 HYPOCALCAEMIA 234 0.0124
744 OVERDOSE 2661 0.0123
745 NEUTROPHIL COUNT INCREASED 126 0.0123
746 PERICARDIAL EFFUSION 284 0.0123
747 RIB FRACTURE 252 0.0122
748 PULMONARY CONGESTION 161 0.0122
749 VERTIGO 742 0.0122
750 GASTRIC ULCER 230 0.0121
751 BODY HEIGHT DECREASED 129 0.0121
752 PANCREATITIS ACUTE 268 0.0119
753 APHONIA 166 0.0119
754 HEPATIC FUNCTION ABNORMAL 442 0.0118
755 GOUT 211 0.0117
756 HAEMORRHAGE 1229 0.0117
757 EYE HAEMORRHAGE 155 0.0116
758 DISEASE RECURRENCE 546 0.0115
759 PHOTOPHOBIA 215 0.0114
760 FEEDING DISORDER 231 0.0114
761 DEAFNESS 294 0.0112
762 POST PROCEDURAL HAEMORRHAGE 130 0.0112
763 HYPERTENSIVE CRISIS 124 0.0111
764 HEPATIC CYTOLYSIS 142 0.0111
765 SWELLING FACE 723 0.0111
766 ANXIETY 3158 0.0111
767 ILLNESS 1143 0.0111
768 DEHYDRATION 1475 0.0110
769 MYALGIA 1877 0.0110
770 HYPOKALAEMIA 506 0.0110
771 INJECTION SITE EXTRAVASATION 135 0.0109
772 PERIPHERAL COLDNESS 150 0.0109
773 RESPIRATORY FAILURE 796 0.0109
774 SENSORY DISTURBANCE 174 0.0108
775 BLOOD TEST ABNORMAL 152 0.0108
776 CARDIOMYOPATHY 159 0.0107
777 TACHYPNOEA 146 0.0107
778 HYPOAESTHESIA ORAL 161 0.0107
779 SEASONAL ALLERGY 151 0.0107
780 NEURALGIA 259 0.0106
781 HEAD DISCOMFORT 187 0.0106
782 RED BLOOD CELL COUNT DECREASED 301 0.0105
783 OCULAR HYPERAEMIA 499 0.0105
784 SHOCK 240 0.0104
785 HIATUS HERNIA 135 0.0104
786 INCORRECT DOSE ADMINISTERED 2341 0.0102
787 RESPIRATORY TRACT CONGESTION 162 0.0102
788 HYPOTENSION 2030 0.0101
789 FALL 3356 0.0101
790 PREMATURE DELIVERY 159 0.0100
791 METASTASES TO LIVER 175 0.0099
792 PERITONITIS 206 0.0099
793 THROMBOCYTOPENIA 1112 0.0099
794 ANAEMIA 1895 0.0099
795 BONE DISORDER 181 0.0099
796 LIP SWELLING 328 0.0098
797 LOCAL SWELLING 169 0.0097
798 PRODUCT PRESCRIBING ERROR 230 0.0096
799 BLOOD POTASSIUM DECREASED 288 0.0096
800 RENAL DISORDER 441 0.0095
801 RENAL FAILURE 1256 0.0094
802 GINGIVAL BLEEDING 129 0.0094
803 SKIN FISSURES 184 0.0094
804 FLATULENCE 533 0.0094
805 FAECES DISCOLOURED 202 0.0093
806 SPINAL FRACTURE 185 0.0092
807 RETCHING 196 0.0092
808 DYSSTASIA 268 0.0092
809 MYELODYSPLASTIC SYNDROME 132 0.0091
810 SKIN DISCOLOURATION 419 0.0091
811 CONSTIPATION 1979 0.0091
812 EYE SWELLING 334 0.0090
813 DYSPHONIA 523 0.0089
814 HYPERSOMNIA 256 0.0089
815 FRACTURE 169 0.0089
816 ACUTE MYELOID LEUKAEMIA 139 0.0089
817 LYMPHOPENIA 126 0.0089
818 SLEEP APNOEA SYNDROME 170 0.0089
819 TINNITUS 409 0.0089
820 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 460 0.0088
821 RASH GENERALISED 228 0.0088
822 ANGINA PECTORIS 251 0.0088
823 GAMMA-GLUTAMYLTRANSFERASE INCREASED 194 0.0087
824 EPISTAXIS 654 0.0087
825 NERVOUS SYSTEM DISORDER 272 0.0087
826 TREMOR 1444 0.0087
827 LEUKOCYTOSIS 157 0.0087
828 ANGIOEDEMA 383 0.0086
829 BLOOD URINE PRESENT 162 0.0085
830 PRODUCT PREPARATION ERROR 175 0.0085
831 HAEMATEMESIS 215 0.0085
832 RENAL IMPAIRMENT 708 0.0084
833 INCORRECT PRODUCT ADMINISTRATION DURATION 182 0.0084
834 TOOTH LOSS 174 0.0084
835 POOR QUALITY SLEEP 178 0.0083
836 HOT FLUSH 622 0.0082
837 HEAD INJURY 261 0.0082
838 BURNING SENSATION 578 0.0082
839 MENTAL DISORDER 358 0.0082
840 TREATMENT NONCOMPLIANCE 445 0.0081
841 RESTLESS LEGS SYNDROME 147 0.0081
842 BLOOD ALKALINE PHOSPHATASE INCREASED 199 0.0080
843 HIP FRACTURE 253 0.0079
844 FEMUR FRACTURE 241 0.0078
845 RASH MACULAR 272 0.0078
846 MYOCARDIAL INFARCTION 1354 0.0078
847 UNEVALUABLE EVENT 582 0.0077
848 PROTEINURIA 146 0.0077
849 PRURITUS GENERALISED 166 0.0077
850 SINUS DISORDER 152 0.0077
851 PROSTATE CANCER 610 0.0076
852 ACUTE RESPIRATORY FAILURE 145 0.0075
853 ATRIAL FIBRILLATION 726 0.0074
854 TRANSIENT ISCHAEMIC ATTACK 251 0.0074
855 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 529 0.0074
856 OSTEONECROSIS 243 0.0074
857 DIPLOPIA 192 0.0074
858 ARRHYTHMIA 348 0.0073
859 BLINDNESS 298 0.0073
860 HAEMATURIA 250 0.0073
861 HEPATIC FAILURE 220 0.0073
862 MULTIPLE ORGAN DYSFUNCTION SYNDROME 206 0.0073
863 HEMIPARESIS 123 0.0073
864 INTENTIONAL PRODUCT MISUSE 633 0.0072
865 HYPOXIA 254 0.0072
866 FEELING ABNORMAL 1728 0.0072
867 CHOLESTASIS 137 0.0071
868 PANCYTOPENIA 395 0.0071
869 RASH PAPULAR 158 0.0070
870 CORONARY ARTERY DISEASE 212 0.0070
871 EYE PAIN 395 0.0070
872 DYSPHAGIA 663 0.0070
873 BLOOD PRESSURE ABNORMAL 138 0.0069
874 RASH MACULO-PAPULAR 154 0.0069
875 ASCITES 203 0.0069
876 PRODUCT QUALITY ISSUE 937 0.0069
877 MELAENA 151 0.0069
878 CARDIAC DISORDER 640 0.0068
879 PANIC ATTACK 249 0.0068
880 DYSURIA 250 0.0068
881 LETHARGY 389 0.0068
882 JAUNDICE 180 0.0067
883 CEREBROVASCULAR ACCIDENT 1120 0.0066
884 NERVOUSNESS 340 0.0065
885 PULMONARY OEDEMA 291 0.0065
886 THERAPEUTIC RESPONSE UNEXPECTED 290 0.0065
887 DYSPNOEA EXERTIONAL 243 0.0064
888 CHOKING 124 0.0063
889 CEREBRAL INFARCTION 155 0.0063
890 LACRIMATION INCREASED 190 0.0063
891 PRODUCT DOSE OMISSION ISSUE 1849 0.0063
892 PANCREATIC CARCINOMA 181 0.0063
893 BLOOD CREATININE INCREASED 403 0.0062
894 NEUROPATHY PERIPHERAL 586 0.0062
895 BONE MARROW FAILURE 125 0.0061
896 URINARY INCONTINENCE 179 0.0060
897 WHITE BLOOD CELL COUNT DECREASED 654 0.0060
898 APHASIA 180 0.0060
899 HAEMATOMA 154 0.0059
900 HYPOTHYROIDISM 189 0.0059
901 RESPIRATORY ARREST 163 0.0059
902 GASTROINTESTINAL HAEMORRHAGE 494 0.0059
903 ACCIDENTAL OVERDOSE 216 0.0059
904 SNEEZING 132 0.0059
905 NIGHTMARE 203 0.0059
906 HAEMOPTYSIS 163 0.0058
907 PRODUCT AVAILABILITY ISSUE 133 0.0058
908 VISION BLURRED 793 0.0058
909 CARDIAC FAILURE 462 0.0057
910 PRODUCT DOSE OMISSION 375 0.0057
911 ACUTE MYOCARDIAL INFARCTION 169 0.0057
912 SOMNOLENCE 1141 0.0057
913 PAIN OF SKIN 152 0.0056
914 RENAL FAILURE ACUTE 238 0.0056
915 SPEECH DISORDER 291 0.0055
916 CARDIAC FAILURE CONGESTIVE 445 0.0055
917 MOOD SWINGS 175 0.0055
918 GASTRIC CANCER 138 0.0054
919 BRADYCARDIA 288 0.0054
920 CONVULSION 309 0.0054
921 BONE PAIN 313 0.0053
922 BREAST CANCER FEMALE 142 0.0053
923 MUCOSAL INFLAMMATION 139 0.0053
924 DRY EYE 265 0.0053
925 DRUG DOSE OMISSION 865 0.0052
926 MULTIPLE SCLEROSIS 250 0.0052
927 HYPOPHAGIA 133 0.0052
928 BLOOD CREATINE PHOSPHOKINASE INCREASED 149 0.0052
929 CRYING 185 0.0051
930 BLADDER CANCER 297 0.0050
931 PNEUMONIA ASPIRATION 125 0.0050
932 NEUTROPENIA 645 0.0047
933 VISUAL ACUITY REDUCED 157 0.0047
934 DEPRESSED MOOD 249 0.0047
935 SKIN EXFOLIATION 393 0.0047
936 EYE PRURITUS 156 0.0046
937 DEMENTIA 128 0.0046
938 DYSGEUSIA 340 0.0046
939 POLLAKIURIA 187 0.0045
940 THERAPY CESSATION 228 0.0044
941 THERAPY INTERRUPTED 317 0.0044
942 PSYCHOTIC DISORDER 128 0.0043
943 RESTLESSNESS 156 0.0043
944 PLATELET COUNT DECREASED 454 0.0043
945 CEREBRAL HAEMORRHAGE 152 0.0042
946 DISEASE PROGRESSION 493 0.0042
947 BALANCE DISORDER 358 0.0041
948 SUICIDAL IDEATION 374 0.0041
949 SEIZURE 466 0.0040
950 CHRONIC KIDNEY DISEASE 301 0.0040
951 DYSARTHRIA 148 0.0039
952 CARDIAC ARREST 322 0.0039
953 URINARY RETENTION 126 0.0038
954 DEPRESSED LEVEL OF CONSCIOUSNESS 148 0.0037
955 RENAL CANCER 177 0.0037
956 HYPONATRAEMIA 208 0.0037
957 DRY SKIN 465 0.0035
958 EYE IRRITATION 198 0.0034
959 HYPOACUSIS 148 0.0034
960 COGNITIVE DISORDER 156 0.0033
961 ACUTE KIDNEY INJURY 509 0.0033
962 VAGINAL HAEMORRHAGE 144 0.0033
963 DISORIENTATION 130 0.0033
964 COMA 156 0.0033
965 HYPOGLYCAEMIA 158 0.0033
966 DISTURBANCE IN ATTENTION 174 0.0032
967 AGITATION 234 0.0032
968 DRUG INTERACTION 494 0.0031
969 CARDIO-RESPIRATORY ARREST 126 0.0030
970 BLOOD GLUCOSE DECREASED 140 0.0029
971 SKIN IRRITATION 130 0.0028
972 DRUG DEPENDENCE 455 0.0028
973 DEATH 2413 0.0028
974 INJECTION SITE SWELLING 214 0.0028
975 SUICIDE ATTEMPT 163 0.0027
976 PRODUCT SUBSTITUTION ISSUE 151 0.0026
977 INJECTION SITE BRUISING 184 0.0023
978 INJECTION SITE PRURITUS 147 0.0022
979 BLOOD GLUCOSE INCREASED 410 0.0022
980 INJECTION SITE PAIN 643 0.0021
981 INJECTION SITE ERYTHEMA 260 0.0021
982 FEBRILE NEUTROPENIA 138 0.0021
983 PRODUCT STORAGE ERROR 181 0.0021
984 NO ADVERSE EVENT 366 0.0020
985 INJECTION SITE HAEMORRHAGE 155 0.0019
986 ACCIDENTAL EXPOSURE TO PRODUCT 177 0.0017
987 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 305 0.0015
988 EMOTIONAL DISTRESS 174 0.0014
989 TOXICITY TO VARIOUS AGENTS 230 0.0014
990 MALIGNANT NEOPLASM PROGRESSION 134 0.0013